Mark Sanz

1.2k total citations
15 papers, 949 citations indexed

About

Mark Sanz is a scholar working on Surgery, Radiology, Nuclear Medicine and Imaging and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Mark Sanz has authored 15 papers receiving a total of 949 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Surgery, 9 papers in Radiology, Nuclear Medicine and Imaging and 8 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Mark Sanz's work include Coronary Interventions and Diagnostics (9 papers), Cardiac Imaging and Diagnostics (9 papers) and Antiplatelet Therapy and Cardiovascular Diseases (3 papers). Mark Sanz is often cited by papers focused on Coronary Interventions and Diagnostics (9 papers), Cardiac Imaging and Diagnostics (9 papers) and Antiplatelet Therapy and Cardiovascular Diseases (3 papers). Mark Sanz collaborates with scholars based in United States, France and Germany. Mark Sanz's co-authors include E G Nabel, Judy A. Walton, Henry H. Hsia, S.W. Werns, B. Pitt, Gregg W. Stone, Krishnankutty Sudhir, James Hermiller, William Newman and Donald E. Cutlip and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and The American Journal of Cardiology.

In The Last Decade

Mark Sanz

15 papers receiving 906 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Sanz United States	8	691	650	356	168	112	15	949
Anna Kalynych United States	16	669 1.0×	757 1.2×	592 1.7×	184 1.1×	61 0.5×	24	1.1k
Nobuo Shiode Japan	15	664 1.0×	601 0.9×	374 1.1×	197 1.2×	112 1.0×	64	962
Yasuhiko Tanabe Japan	16	939 1.4×	347 0.5×	674 1.9×	121 0.7×	72 0.6×	41	1.2k
B Cassagneau France	10	464 0.7×	421 0.6×	310 0.9×	120 0.7×	37 0.3×	38	639
Tetsuari Onishi Japan	20	1.2k 1.7×	301 0.5×	356 1.0×	273 1.6×	92 0.8×	73	1.4k
Yoku Kikuchi Japan	16	490 0.7×	264 0.4×	399 1.1×	65 0.4×	81 0.7×	35	804
Anil Mehra United States	11	816 1.2×	345 0.5×	71 0.2×	171 1.0×	71 0.6×	25	930
Junichiro Kondo Japan	13	643 0.9×	431 0.7×	382 1.1×	40 0.2×	54 0.5×	25	871
Stuart Hood United Kingdom	16	876 1.3×	444 0.7×	768 2.2×	59 0.4×	41 0.4×	37	1.1k
Xiaofan Wu China	13	355 0.5×	331 0.5×	259 0.7×	206 1.2×	106 0.9×	36	687

Countries citing papers authored by Mark Sanz

Since Specialization

Citations

This map shows the geographic impact of Mark Sanz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Sanz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Sanz more than expected).

Fields of papers citing papers by Mark Sanz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Sanz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Sanz. The network helps show where Mark Sanz may publish in the future.

Co-authorship network of co-authors of Mark Sanz

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Sanz. A scholar is included among the top collaborators of Mark Sanz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Sanz. Mark Sanz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Chang, Shu‐Ching, et al.. (2016). A Method to Estimate the Mean Lifetime Survival Increase of Statin Therapy. Future Cardiology. 12(5). 539–544. 1 indexed citations

Gada, Hemal, Ajay J. Kirtane, William Newman, et al.. (2013). 5-Year Results of a Randomized Comparison of XIENCE V Everolimus-Eluting and TAXUS Paclitaxel-Eluting Stents. JACC: Cardiovascular Interventions. 6(12). 1263–1266. 154 indexed citations

Hermiller, James, Eugenia Nikolsky, Alexandra J. Lansky, et al.. (2011). Clinical and angiographic outcomes of elderly patients treated with everolimus-eluting versus paclitaxel-eluting stents: three-year results from the SPIRIT III randomised trial. EuroIntervention. 7(3). 307–313. 14 indexed citations

Applegate, Robert J., James Hermiller, Mark Sanz, et al.. (2010). Comparison of everolimus-eluting and paclitaxel-eluting coronary stents in patients with two treated vessels: 2-year results from the SPIRIT III randomised trial. EuroIntervention. 6(4). 437–446. 5 indexed citations

Lansky, Alexandra J., Manejeh Yaqub, James Hermiller, et al.. (2010). Side branch occlusion with everolimus-eluting and paclitaxel-eluting stents: three-year results from the SPIRIT III randomised trial. EuroIntervention. 6(J). J44–J52. 24 indexed citations

Lansky, Alexandra J., Vivian G. Ng, Ecaterina Cristea, et al.. (2009). Gender‐based evaluation of the XIENCE V™ everolimus‐eluting coronary stent system:. Catheterization and Cardiovascular Interventions. 74(5). 719–727. 34 indexed citations

Stone, Gregg W., Mark Midei, William Newman, et al.. (2009). Randomized Comparison of Everolimus-Eluting and Paclitaxel-Eluting Stents. Circulation. 119(5). 680–686. 218 indexed citations

Sanz, Mark, Richard W. Smalling, William J. French, et al.. (2007). Development of Systems of Care for ST-Elevation Myocardial Infarction Patients. Circulation. 116(2). e39–42. 7 indexed citations

Joudinaud, Thomas, et al.. (2005). An experimental method for the percutaneous induction of a posterolateral infarct and functional ischemic mitral regurgitation.. PubMed. 14(4). 460–6. 6 indexed citations

10.

Topol, Eric J., Robert M. Califf, Michel Vandormael, et al.. (1992). A randomized trial of late reperfusion therapy for acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction-6 Study Group.. Circulation. 85(6). 2090–2099. 149 indexed citations

11.

Topol, Eric J., Stephen G. Ellis, Thomas C. Wall, et al.. (1991). Does late reperfusion therapy for myocardial infarction improve left ventricular function? preliminary results of the TAMI-6 randomized, controlled trial. Journal of the American College of Cardiology. 17(2). A45–A45. 3 indexed citations

12.

Werns, S.W., Judy A. Walton, Henry H. Hsia, et al.. (1989). Evidence of endothelial dysfunction in angiographically normal coronary arteries of patients with coronary artery disease.. Circulation. 79(2). 287–291. 264 indexed citations

13.

Sanz, Mark, G.B.John Mancini, Michael T. LeFree, et al.. (1987). Variability of quantitative digital subtraction coronary angiography before and after percutaneous transluminal coronary angioplasty. The American Journal of Cardiology. 60(1). 55–60. 67 indexed citations

14.

Sanz, Mark, et al.. (1985). Ischemic heart disease: Part of the premenstrual syndrome?. American Heart Journal. 110(3). 672–673. 1 indexed citations

15.

Herreros, Jesús, et al.. (1985). [Nutritional and immunologic state of patients undergoing heart valve surgery].. PubMed. 122(12). 707–10. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact